INBX
Price
$34.69
Change
+$0.25 (+0.73%)
Updated
May 9, 6:59 PM EST
88 days until earnings call
RAPT
Price
$4.66
Change
-$3.32 (-41.60%)
Updated
May 9, 6:59 PM EST
91 days until earnings call
Ad is loading...

INBX vs RAPT

Header iconINBX vs RAPT Comparison
Open Charts INBX vs RAPTBanner chart's image
Inhibrx
Price$34.69
Change+$0.25 (+0.73%)
Volume$206.44K
CapitalizationN/A
RAPT Therapeutics
Price$4.66
Change-$3.32 (-41.60%)
Volume$3.09M
CapitalizationN/A
View a ticker or compare two or three
INBX vs RAPT Comparison Chart

Loading...

INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RAPTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
INBX vs. RAPT commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Buy and RAPT is a Hold.

COMPARISON
Comparison
May 10, 2024
Stock price -- (INBX: $34.44 vs. RAPT: $7.98)
Brand notoriety: INBX and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 66% vs. RAPT: 61%
Market capitalization -- INBX: $1.63B vs. RAPT: $277.7M
INBX [@Biotechnology] is valued at $1.63B. RAPT’s [@Biotechnology] market capitalization is $277.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 5 TA indicator(s) are bullish while RAPT’s TA Score has 3 bullish TA indicator(s).

  • INBX’s TA Score: 5 bullish, 3 bearish.
  • RAPT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INBX is a better buy in the short-term than RAPT.

Price Growth

INBX (@Biotechnology) experienced а +0.41% price change this week, while RAPT (@Biotechnology) price change was -2.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.21%. For the same industry, the average monthly price growth was -4.72%, and the average quarterly price growth was +71.05%.

Reported Earning Dates

INBX is expected to report earnings on Aug 05, 2024.

RAPT is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+0.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for INBX with price predictions.
OPEN
A.I.dvisor published
a Summary for RAPT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
INBX($1.63B) has a higher market cap than RAPT($278M). INBX YTD gains are higher at: -9.368 vs. RAPT (-67.887).
INBXRAPTINBX / RAPT
Capitalization1.63B278M587%
EBITDAN/AN/A-
Gain YTD-9.368-67.88714%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
INBXRAPT
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend about 1 month ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RAPTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMUIX21.890.16
+0.74%
MFS Utilities I
VICEX21.350.10
+0.47%
USA Mutuals Vice Investor
QIACX43.080.09
+0.21%
Federated Hermes MDT All Cap Core IS
HRMVX26.310.01
+0.04%
Harbor Mid Cap Value Admin
OWLSX18.95-0.04
-0.21%
Old Westbury Large Cap Strategies

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+0.15%
AXON - INBX
48%
Loosely correlated
-0.28%
AKRO - INBX
44%
Loosely correlated
-4.54%
PCVX - INBX
42%
Loosely correlated
-1.08%
SNTI - INBX
39%
Loosely correlated
-0.52%
KYMR - INBX
39%
Loosely correlated
+0.16%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-1.24%
AXON - RAPT
48%
Loosely correlated
-0.28%
SNDX - RAPT
45%
Loosely correlated
-3.45%
OCUL - RAPT
42%
Loosely correlated
-3.04%
AGIO - RAPT
41%
Loosely correlated
-1.04%
NRIX - RAPT
41%
Loosely correlated
-1.27%
More